NS-018
- CAS No.
- 1239358-86-1
- Chemical Name:
- NS-018
- Synonyms
- Ilginatinib;NS-018;NS018;ILGINATINIB;ILGINATINIB (NS-018);Ilginatinib, 10 mM in DMSO;JAK3,Janus kinase,Inhibitor,NS 018,JAK,JAK2,orally,Tyk2,NS018,Ilginatinib,inhibit,JAK1,bioavailable;2,6-Pyridinediamine, N2-[(1S)-1-(4-fluorophenyl)ethyl]-4-(1-methyl-1H-pyrazol-4-yl)-N6-2-pyrazinyl-;N2-[(1S)-1-(4-fluorophenyl)ethyl]-4-(1-methyl-1H-pyrazol-4-yl)-N6-(pyrazin-2-yl)pyridine-2,6-diamine
- CBNumber:
- CB83067013
- Molecular Formula:
- C21H20FN7
- Molecular Weight:
- 389.43
- MDL Number:
- MFCD28502056
- MOL File:
- 1239358-86-1.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Boiling point | 574.1±50.0 °C(Predicted) |
|---|---|
| Density | 1.31±0.1 g/cm3(Predicted) |
| storage temp. | Store at -20°C |
| solubility | DMSO : ≥ 34 mg/mL (87.31 mM) |
| form | Solid |
| pka | 2.43±0.10(Predicted) |
| color | Light yellow to yellow |
| FDA UNII | 56R994WX4L |
| NCI Drug Dictionary | ilginatinib |
NS-018 price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Biosynth | PZB35886 | Ilginatinib | 1239358-86-1 | 10mg | $662.7 | 2026-06-04 | Buy |
| Biosynth | PZB35886 | Ilginatinib | 1239358-86-1 | 25mg | $1242.5 | 2026-06-04 | Buy |
| Biosynth | PZB35886 | Ilginatinib | 1239358-86-1 | 50mg | $1988.5 | 2026-06-04 | Buy |
| ChemScene | CS-5358 | Ilginatinib 99.94% | 1239358-86-1 | 1mg | $106 | 2026-06-04 | Buy |
| ChemScene | CS-5358 | Ilginatinib 99.94% | 1239358-86-1 | 5mg | $213 | 2026-06-04 | Buy |
NS-018 Chemical Properties,Uses,Production
Uses
Ilginatinib (NS-018) is a highly active and orally bioavailable JAK2 inhibitor, with an IC50 of 0.72 nM, 46-, 54-, and 31-fold selectivity for JAK2 over JAK1 (IC50, 33 nM), JAK3 (IC50, 39 nM), and Tyk2 (IC50, 22 nM).
in vivo
Ilginatinib (NS-018) (12.5, 25, 50, 100 mg/kg, p.o.) potently prolongs the survival of mice and reduces splenomegaly in a mouse Ba/F3-JAK2V617F disease model[1].
Ilginatinib (NS-018) (25, 50 mg/kg, p.o.) significantly reduces leukocytosis, hepatosplenomegaly and extramedullary hematopoiesis, improves nutritional status, and prolongs survival in JAK2V617F transgenic mice
IC 50
JAK2: 0.72 nM (IC50); Tyk2: 22 nM (IC50); JAK1: 33 nM (IC50); JAK3: 39 nM (IC50)
References
[1] Nakaya Y, et al. Efficacy of NS-018, a potent and selective JAK2/Src inhibitor, in primary cells and mouse models of myeloproliferative neoplasms. Blood Cancer J. 2011 Jul;1(7):e29. DOI:10.1038/bcj.2011.29
[2] Kuroda J, et al. NS-018, a selective JAK2 inhibitor, preferentially inhibits CFU-GM colony formation by bone marrow mononuclear cells from high-risk myelodysplastic syndrome patients. Leuk Res. 2014 May;38(5):619-24. DOI:10.1016/j.leukres.2014.03.001
NS-018 Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| BOC Sciences | 1-631-485-4226; 16314854226 | info@bocsci.com | United States | 9920 | 65 |
| Haoyuan Chemexpress Co., Ltd. | 021-58950125 | info@chemexpress.com | China | 7545 | 61 |
| MedChemexpress LLC | 021-58955995 | sales@medchemexpress.cn | United States | 4853 | 58 |
| Shanghai Lollane Biological Technology Co.,Ltd. | 021-52996696,15000506266 15000506266 | China | 4861 | 55 | |
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| ShangHai Biochempartner Co.,Ltd | 177-54423994 17754423994 | 2853530910@QQ.com | China | 8000 | 62 |
| Shanghai Rechem science Co., Ltd. | 021-31433387 15618786686 | sales@rechemscience.com | China | 2971 | 58 |
| Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131885 | 58 |
| Musechem | +1-800-259-7612 | info@musechem.com | United States | 4648 | 60 |
| Angel Pharmatech, Ltd. | 17317130613 | 3358272972@qq.com | China | 3307 | 58 |
View Lastest Price from NS-018 manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-27 | Ilginatinib
1239358-86-1
|
$58.00-196.00 | 98.40% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2026-07-27 | Ilginatinib
1239358-86-1
|
$58.00-196.00 | 98.40% | 10g | TargetMol Chemicals Inc. |
-

- Ilginatinib
1239358-86-1
- $58.00-196.00
- 98.40%
- TargetMol Chemicals Inc.
-

- Ilginatinib
1239358-86-1
- $58.00-196.00
- 98.40%
- TargetMol Chemicals Inc.




